Models of affective illness: Chronic mild stress in the rat

Current Protocols in Pharmacology

Volumn , Issue SUPPL.57, 2012, Pages

  Papp, Mariusz ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Anhedonia; Animal model; Antidepressants; Chronic stress; Depression

Indexed keywords

CITALOPRAM; IMIPRAMINE; SUCROSE; ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE INTAKE; CHRONIC DISEASE; CHRONIC MILD STRESS; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; DRUG WITHDRAWAL; MALE; MENTAL STRESS; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; ANHEDONIA; ANIMAL; ANIMAL HUSBANDRY; DEPRESSION; DRUG EFFECT; PSYCHOLOGICAL ASPECT; WISTAR RAT;

ANHEDONIA; ANIMAL HUSBANDRY; ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SUCROSE;

EID: 84865371831     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0509s57     Document Type: Article

References (36)

1. Adham, N., Gyertyán, I., Kiss, B., Gupta, S., Gruca, P., Litwa, E., and Papp, M. 2007. Antidepressant activity of RGH-188, a potential antipsychotic with D3/D2 antagonist/partial agonist properties in a chronic mild stress-induced anhedonia model. Neuroscience Meeting, Poster no. 906.11.
2. Adham, N., Caron, MG., Gyertyán, I., Gruca, P., Kiss, B., Lason-Tyburkiewicz, M., Szombathelyi, Z., and Papp, M. 2010. Cariprazine, a D3-preferring dopamine D3/D2 receptor partial agonist, has antidepressant-like activity with fast onset of action in the chronic mild stressinduced anhedonia model. Neuropsychopharmacology 35:171.
3. Brocco, M., Dekeyne, A., Papp, M., and Millan, M.J. 2006. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: Mediation by dopamine D2 receptors. Behav. Pharmacol. 17:559-572.
4. Casarotto, P.C. and Andreatini, R. 2007. Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur. Neuropsychopharmacol. 17:735-742.
5. Der-Avakian, A. and Markou, A. 2012. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 35:68-77.
6. Garcia, L.S., Comim, C.M., Valvassori, S.S., Réus, G.Z., Stertz, L., Kapczinski, F., Gavioli, E.C., and Quevedo, J. 2009. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:450-455.
7. Gersner, R., Toth, E., Isserles, M., and Zangen, A. 2010. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: Potential role of brain-derived neurotrophic factor. Biol. Psychiatry 67:125-132.
8. Gruca, P., Lason-Tyburkiewicz, M., and Papp, M. 2011. Evidence for antidepressant- and anxiolytic-like properties of ketamine in animal models. Pharmacol. Rep. 63:565-566.
9. Katz, R.J. 1982. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16:965-968.
10. Marston, H.M., Martin, F.D., Papp, M., Gold, L., Wong, E.H., and Shahid, M. 2010. Attenuation of chronic mild stress-induced "anhedonia" by asenapine is not associated with a "hedonic" profile in intracranial self-stimulation. J. Psychopharmacol. 25:1388-1398.
11. Millan, M.J., Dekeyne, A., Papp, M., Rochelle, C.D., MacSweeny, C., and Brocco, M. 2001. S33005, a novel ligand at both serotonin and norepinephrine transporters: ii. behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J. Pharmacol. Exp. Ther. 298:581-591.
12. Montgomery, S.A., Loft, H., Sánchez, C., Reines, E.H., and Papp, M. 2001. Escitalopram (Senantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model. Pharmacol. Toxicol. 88:282-286.
13. Moreau, J-L., Jenck, F., Martin, J.R., Mortas, P., and Haefely, W.E. 1992. Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behaviour in rats. Eur. Neuropsychopharmacol. 2:43-49.
14. Moreau, J-L., Scherschlict, R., Jenck, F., and Martin, J.R. 1995. Chronic mild stress-induced anhedonia model of depression: Sleep abnormalities and curative effects of electroshock treatment. Behav. Pharmacol. 6:682-687.
15. Muñoz, C. and Papp, M. 1999. Alnespirone (S 20499), an agonist of 5-HT1A receptors, and imipramine have similar activity in a chronic mild stress model of depression. Pharmacol. Biochem. Behav. 63:647-653.
16. Muscat, R., Papp, M., and Willner, P. 1992. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotoline. Psychopharmacology 109:433-438.
17. Orsetti, M., Canonico, P.L., Dellarole, A., Colella, L., Di Brisco, F., and Ghi, P. 2007a. Quetiapine prevents anhedonia induced by acute or chronic stress. Neuropsychopharmacology 32:1783-1790.
18. Orsetti, M., Colella, L., Dellarole, A., Canonico, P.L., and Ghi, P. 2007b. Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats. Int. J. Neuropsychopharmacol. 10:345-357.
19. Ossowska, G., Danilczuk, Z., Klenk-Majewska, B., Czajkowski, L., and Zebrowska-Łupina, I. 2004. Antidepressants in chronic unpredictable mild stress (CUMS)-induced deficit of fighting behavior. Pol. J. Pharmacol. 56:305-311.
20. Papp, M. and Wieronska, J. 2000. Antidepressantlike effects of amisulpride in two animal models of depression. J. Psychopharmacol. 14:46-52.
21. Papp, M., Willner, P., and Muscat, R. 1991. An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104:255-259.
22. Papp, M., Lappas, S., Muscat, R., and Willner, P. 1992. Attenuation of place preference conditioning but not place aversion conditioning by chronicmild stress. J. Psychopharmacol. 6:352-356.
23. Papp, M., Muscat, R., and Willner, P. 1993. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110:152-158.
24. Papp, M., Klimek, V., and Willner, P. 1994a. Effects of imipramine on serotonergic and betaadrenergic receptor binding in a realistic animal model of depression. Psychopharmacology 114:309-314.
25. Papp, M., Nalepa, I., and Vetulani, J. 1994b. Reversal by imipramine of beta-adrenoceptor upregulation induced in a chronic mild stress model of depression. Eur. J. Pharmacol. 261:141-147.
26. Papp, M., Klimek, V., and Willner, P. 1994c. Parallel changes in dopamine D-2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441-446.
27. Papp, M., Moryl, E., and Willner, P. 1996. Pharmacological validation of the chronic mild stress model of depression. Eur. J. Pharmacol. 296:129-136.
28. Papp, M., Gruca, P., Boyer, P-A., and Mocäer, E. 2003. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28:694-703.
29. Papp, M., Panconi, E., and Gruca, P. 2004. Effects of the novel antidepressant milnacipran in a chronic mild stress model of depression. Drug Dev. Res. 61:101-106.
30. Przegalinski, E., Moryl, E., and Papp, M. 1995. The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34:1305-1310.
31. Sanchez, C., Gruca, P., and Papp, M. 2003. R-citalopram counteracts the antidepressantlike effect of escitalopram in a rat chronic mild stress model. Behav. Pharmacol. 14:465-470.
32. Sluzewska, A. and Nowakowska, E. 1994. The effects of carbamazepine, lithium and ketoconazole in chronic mild stress model of depression in rats. Behav. Pharmacol. 5:86.
33. Stahl, S.M., Kaiser, L., Roeschen, J., Keppel Hesselink, J.M., and Orazem, J. 1998. Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: Support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants. Int. J. Neuropsychopharmacol. 1:11-18.
34. Willner, P., Muscat, R., and Papp, M. 1992. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci. Biobehav. Rev. 16:525-534.
35. Willner, P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology 134:319-329.
36. Willner, P. 2005. Chronic mild stress (CMS) revisited: Consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110.